|
National Stock Number(NSN): 6505-01-337-0319 (6505013370319, 013370319)
| NIIN: |
01-337-0319 |
Item Name: |
CEFTAZIDIME FOR INJECTION |
INC: |
42844
|
| FSC: |
6505
|
Assignment Date: |
Apr-09-1991 |
CRIT: |
X |
IIG: |
42844 |
| ISC: |
2 |
Date Standardized: |
Apr-09-1991 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
3004.90.9240 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
91-0115 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
CEPTAZ |
34006
|
GLAXO WELLCOME INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00173-0414-00 |
34006
|
GLAXO WELLCOME INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
Y |
|
M |
U |
1 |
A |
$232.02 |
PG |
|
C2201X- |
Dec-01-1999 |
H |
| DF |
S9M |
H |
|
M |
U |
1 |
F |
$232.02 |
PG |
|
------- |
Oct-01-1999 |
H |
| DN |
S9M |
Y |
|
M |
U |
1 |
N |
$232.02 |
PG |
|
9L----- |
Dec-01-1999 |
H |
| DS |
S9M |
Y |
|
M |
U |
1 |
D |
$232.02 |
PG |
|
------- |
Dec-01-1999 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 25EA |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 GRAMS OF ACTIVE INGREDIENT |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
25 |
| FEAT |
SPECIAL FEATURES |
WITH HANGING DEVICE FOR INTERMITTENT INTRAVENOUS ADMINISTRATION |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|